|
Risk Factor Set
|
Observed proportion (N) in risk set
|
Positive Predictive Value
|
Sensitivity
|
Specificity
|
Proportion correctly predicted
|
|---|
|
NCEP-ATP III Metabolic Syndrome
|
50.2% (2495)
|
98.1%
|
95.4%
|
98.2%
|
96.8%
|
|
IDF Metabolic Syndrome
|
55.2% (2744)
|
98.7%
|
98.7%
|
98.3%
|
98.5%
|
|
Abdominal Obesity1 (AO1)
|
76.4% (3795)
|
94.2%
|
88.0%
|
82.6%
|
86.8%
|
|
AO1 and DM
|
13.6% (675)
|
98.8%
|
95.3%
|
99.8%
|
99.2%
|
|
AO1 and Dyslipidemia
|
45.2% (2243)
|
96.9%
|
90.7%
|
97.6%
|
94.5%
|
|
AO1, DM and Dyslipidemia
|
9.6% (479)
|
98.9%
|
96.0%
|
99.9%
|
99.5%
|
|
Abdominal Obesity 2
|
91.8% (4560)
|
95.7%
|
97.0%
|
51.4%
|
93.2%
|
-
NCEP-ATP III National Cholesterol Education Program, Adult Treatment Panel III.
-
IDF International Diabetes Foundation.
- Abdominal Obesity 1: ≥ 88 cm.
- Abdominal Obesity 2: ≥ 80 cm.
-
DM Diabetes Mellitus.
